Alterations of RNA metabolism by proteomic analysis of breast cancer cells exposed to marycin: A new optically active porphyrin

Elena Taverna, Maida De Bortoli, Elisa Maffioli, Cristina Corno, Emilio Ciusani, Silvio Trivulzio, Arnaldo Pinelli, Gabriella Tedeschi, Paola Perego, Italia Bongarzone

Research output: Contribution to journalArticle

Abstract

Objective: Marycin is a porphyrin-type compound synthetically modified to spontaneously release fluorescence. This study is aimed at understanding possible mechanisms that could account for the antiproliferative effects observed in marycin. A proteomic approach was used to identify molecular effects. The proteome of proliferating MDA-MB-231 breast cancer cells was compared with that of marycin-treated cells. Methods: Label-free proteomic analysis by liquid chromatography coupled with tandem mass spec-trometry (LC-MS/MS) was used to reveal changes in protein expression and fluorescence microscopy and flow cytometry were used to detect subcellular organelle dysfunctions. Results: The bioinformatic analysis indicated an enhancement of the expression of proteins remodeling RNA splicing and more in general, of RNA metabolism. Marycin did not localize into the mitochondria and did not produce a dramatic increase of ROS levels in MDA-MB-231 cells. Marycin stained organelles probably peroxisomes. Conclusions: The results could support the possibility that the peroxisomes are involved in cell response to marycin.

Original languageEnglish
Pages (from-to)147-159
Number of pages13
JournalCurrent Molecular Pharmacology
Volume12
Issue number2
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Porphyrins
Proteomics
RNA
Breast Neoplasms
Peroxisomes
Organelles
RNA Splicing
Proteome
Computational Biology
Fluorescence Microscopy
Liquid Chromatography
marycin
Flow Cytometry
Mitochondria
Proteins
Fluorescence

Keywords

  • Anti-proliferative effect
  • LC-MS/MS
  • Marycin
  • MDA-MB-231 breast cancer cells
  • Peroxisomes
  • Porphyrin
  • RNA metabolism
  • RNA splicing

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Alterations of RNA metabolism by proteomic analysis of breast cancer cells exposed to marycin : A new optically active porphyrin. / Taverna, Elena; De Bortoli, Maida; Maffioli, Elisa; Corno, Cristina; Ciusani, Emilio; Trivulzio, Silvio; Pinelli, Arnaldo; Tedeschi, Gabriella; Perego, Paola; Bongarzone, Italia.

In: Current Molecular Pharmacology, Vol. 12, No. 2, 01.01.2019, p. 147-159.

Research output: Contribution to journalArticle

Taverna, Elena ; De Bortoli, Maida ; Maffioli, Elisa ; Corno, Cristina ; Ciusani, Emilio ; Trivulzio, Silvio ; Pinelli, Arnaldo ; Tedeschi, Gabriella ; Perego, Paola ; Bongarzone, Italia. / Alterations of RNA metabolism by proteomic analysis of breast cancer cells exposed to marycin : A new optically active porphyrin. In: Current Molecular Pharmacology. 2019 ; Vol. 12, No. 2. pp. 147-159.
@article{277c32b9556344f784e2a5f566a50eb8,
title = "Alterations of RNA metabolism by proteomic analysis of breast cancer cells exposed to marycin: A new optically active porphyrin",
abstract = "Objective: Marycin is a porphyrin-type compound synthetically modified to spontaneously release fluorescence. This study is aimed at understanding possible mechanisms that could account for the antiproliferative effects observed in marycin. A proteomic approach was used to identify molecular effects. The proteome of proliferating MDA-MB-231 breast cancer cells was compared with that of marycin-treated cells. Methods: Label-free proteomic analysis by liquid chromatography coupled with tandem mass spec-trometry (LC-MS/MS) was used to reveal changes in protein expression and fluorescence microscopy and flow cytometry were used to detect subcellular organelle dysfunctions. Results: The bioinformatic analysis indicated an enhancement of the expression of proteins remodeling RNA splicing and more in general, of RNA metabolism. Marycin did not localize into the mitochondria and did not produce a dramatic increase of ROS levels in MDA-MB-231 cells. Marycin stained organelles probably peroxisomes. Conclusions: The results could support the possibility that the peroxisomes are involved in cell response to marycin.",
keywords = "Anti-proliferative effect, LC-MS/MS, Marycin, MDA-MB-231 breast cancer cells, Peroxisomes, Porphyrin, RNA metabolism, RNA splicing",
author = "Elena Taverna and {De Bortoli}, Maida and Elisa Maffioli and Cristina Corno and Emilio Ciusani and Silvio Trivulzio and Arnaldo Pinelli and Gabriella Tedeschi and Paola Perego and Italia Bongarzone",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/1874467212666190204102112",
language = "English",
volume = "12",
pages = "147--159",
journal = "Current Molecular Pharmacology",
issn = "1874-4702",
publisher = "Bentham Science Publishers",
number = "2",

}

TY - JOUR

T1 - Alterations of RNA metabolism by proteomic analysis of breast cancer cells exposed to marycin

T2 - A new optically active porphyrin

AU - Taverna, Elena

AU - De Bortoli, Maida

AU - Maffioli, Elisa

AU - Corno, Cristina

AU - Ciusani, Emilio

AU - Trivulzio, Silvio

AU - Pinelli, Arnaldo

AU - Tedeschi, Gabriella

AU - Perego, Paola

AU - Bongarzone, Italia

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Marycin is a porphyrin-type compound synthetically modified to spontaneously release fluorescence. This study is aimed at understanding possible mechanisms that could account for the antiproliferative effects observed in marycin. A proteomic approach was used to identify molecular effects. The proteome of proliferating MDA-MB-231 breast cancer cells was compared with that of marycin-treated cells. Methods: Label-free proteomic analysis by liquid chromatography coupled with tandem mass spec-trometry (LC-MS/MS) was used to reveal changes in protein expression and fluorescence microscopy and flow cytometry were used to detect subcellular organelle dysfunctions. Results: The bioinformatic analysis indicated an enhancement of the expression of proteins remodeling RNA splicing and more in general, of RNA metabolism. Marycin did not localize into the mitochondria and did not produce a dramatic increase of ROS levels in MDA-MB-231 cells. Marycin stained organelles probably peroxisomes. Conclusions: The results could support the possibility that the peroxisomes are involved in cell response to marycin.

AB - Objective: Marycin is a porphyrin-type compound synthetically modified to spontaneously release fluorescence. This study is aimed at understanding possible mechanisms that could account for the antiproliferative effects observed in marycin. A proteomic approach was used to identify molecular effects. The proteome of proliferating MDA-MB-231 breast cancer cells was compared with that of marycin-treated cells. Methods: Label-free proteomic analysis by liquid chromatography coupled with tandem mass spec-trometry (LC-MS/MS) was used to reveal changes in protein expression and fluorescence microscopy and flow cytometry were used to detect subcellular organelle dysfunctions. Results: The bioinformatic analysis indicated an enhancement of the expression of proteins remodeling RNA splicing and more in general, of RNA metabolism. Marycin did not localize into the mitochondria and did not produce a dramatic increase of ROS levels in MDA-MB-231 cells. Marycin stained organelles probably peroxisomes. Conclusions: The results could support the possibility that the peroxisomes are involved in cell response to marycin.

KW - Anti-proliferative effect

KW - LC-MS/MS

KW - Marycin

KW - MDA-MB-231 breast cancer cells

KW - Peroxisomes

KW - Porphyrin

KW - RNA metabolism

KW - RNA splicing

UR - http://www.scopus.com/inward/record.url?scp=85065081348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065081348&partnerID=8YFLogxK

U2 - 10.2174/1874467212666190204102112

DO - 10.2174/1874467212666190204102112

M3 - Article

C2 - 30714537

AN - SCOPUS:85065081348

VL - 12

SP - 147

EP - 159

JO - Current Molecular Pharmacology

JF - Current Molecular Pharmacology

SN - 1874-4702

IS - 2

ER -